Clinical testing of Iohexol, Conray meglumine and Amipaque in cerebral angiography

International Nuclear Information System (INIS)

Ingstrup, H.M.; Hauge, P.

1982-01-01

Iohexol 300 mg I/ml, Conray meglumine 282 mg I/mol and Amipaque 300 mg I/ml have been compared in a randomized double-blind cross over study in which one injection of Iohexol 300 mg I/ml and Conray meglumine 282 mg I/ml was made in the same artery (common and internal carotid artery) of the same patient, and one injection of Iohexol 300 mg I/ml and Amipaque 300 mg I/ml was made in another artery (external carotid artery and vertebral artery). All together 63 cerebral artery branches were examined in 27 patients, who served as their own controls. The effect of the contrast injections on the intraarterial blood pressure, pulse rate, ECG, circulatory rate and the patients' reactions were recorded under standardized conditions. The quality of the film was also evaluated. No significant difference was found in the cardiovascular effects after the injection of Iohexol or Conray meglumine into the common carotid, internal carotid, external carotid, or vertebral arteries. There was significantly less pain and sensation of warmth after the injection of Iohexol than after Conray meglumine 282. In the vertebral artery, where a comparison between Iohexol and Amipaque was carried out, was found that. There was also less sensation of warmth after the injection of Amipaque into the vertebral artery than was caused by Iohexol. The degree of discomfort in form of pain reaction was the same for the two media, when these reactions occurred. No serious side effects were observed. (orig.)

Complications after lumbar myelography with amipaque

International Nuclear Information System (INIS)

Lee, Jong Beum; Kim, Seung Hyun; Oh, Seung Chul; Lee, Yong Chul; Lee, Kwan Seh

1982-01-01

Amipaque is a water soluble, non-ionic myelographic contrast media, and owing to its high diagnostic accuracy and safety, its use is gradually increasing. The authors studied the complication after amipaque lumber myelography in 61 patients with low back pain during the period from January 1981 to November 1981 in Chung Ang University Hospital. The results were as follows: 1. Total complication rate was 52% (32 of 61)and there was no sexual difference in its occurrence. 2. In total, no difference in complication rate was found between head-up positioned group with a degree of 30 .deg. (group I) after procedure and head-up positioned group with a degree of 70 .deg. (group II) but female patients had more complication rate in group I than in group II (75% vs 50%). Headache was more common in group I and nausea was more common in group II. 3. Headache was most common complication (44%) and there was no sexual difference in its occurrence. 4. No significance difference in complication rate was found between patients proved to have HNP and patients to have not. 5. Complications were less common in patients with punctured level of L 4-5 than in patients with L 2-3 or L 3-4 level punture

The use of metrizamide (amipaque) to visualise the gastrointestinal tract in children

International Nuclear Information System (INIS)

Cohen, M.; Smith, W.L.; Smith, J.A.; Gresham, E.L.; Schreiner, R.; Lemons, J.

1980-01-01

Metrizamide (amipaque) has not been used previously as a diagnostic contrast agent in the gastrointestinal tract. Metrizamide is a water-soluble isotonic contrast material having many advantages over barium and existing hypertonic water-soluble agents. There are many clinical situations in children in which metrizamide should be the contrast agent of choice for investigating the gastrointestinal tract. Four neonates are presented in whom barium or gastrografin were absolutely contraindicated. In each case metrizamide gave excellent visualisation of the gastrointestinal tract. It could be followed through the bowel giving excellent visualisation even up to 120h after ingestion. No harmful effects were noted in the four cases studied. (author)

Two new contrast media in coronary angiography

International Nuclear Information System (INIS)

Selin, K.; Bjoerk, L.

1983-01-01

Amipaque, ioxaglic acid and Isopaque Coronar 300 were compared in a double blind investigation of coronary angiography in patients with ischemic heart disease. Amipaque affected systolic blood pressure and ECG less than the other contrast media. Ioxaglic acid appeared to give more ST and T changes than Isopaque Coronar. (Auth.)

Effect of meglumine metrizoate and metrizamide on the microcirculation

International Nuclear Information System (INIS)

Ekeland, A.; Uflacker, R.

1978-01-01

Physiologic saline, meglumine metrizoate (Isopaque) and metrizamide (Amipaque) were injected into the ear artery of Wedder rabbits. The effect on the microcirculation in previously inserted ear chambers was recorded by cinematography. Following injection of the contrast media, the circulation was slow, followed by a phase with arteriolo-venular shunting and poor capillary circulation. (Auth.)

Late meningeal changes after Dimer-X-myelography in the absence of surgery

Energy Technology Data Exchange (ETDEWEB)

Assmann, H; Besel, R; Schumann, E; Usbeck, W

1981-04-01

Myelography with Amipaque was carried out in a group of 28 patients who had had previous Dimer-X-myelography, but no surgery. In 12 cases there was radiological evidence of a meningeal reaction. In all these cases there were chronic changes in the lumbar subarachnoid space. The original myelograms showed no evidence of adhesive changes in the root pouches. It was not possible to correlate the radiological findings of the meningeal changes with the serverity or type of neurological diseases.

Excretion of metrizamide (Amipaque) in humans following lumbar subarachnoid injection

International Nuclear Information System (INIS)

Amundsen, P.; Weber, H.; Hoel, L.; Golman, K.

1979-01-01

The excretion of metrizamide through the kidneys and intestinal tract was determined in 10 patients submitted to myelography because of sciatica, for a period of 7 days following the examination. In the faeces, less than 5 per cent of the injected contrast medium was recovered during this period. Total recovery in the urine varied considerably from patient to patient, but most of the contrast medium was excreted during the first 48 hours. From the fourth day on, only small amounts were excreted, but even on the 7th day 3 to 11 mg iodine remained, which corresponds to 6 to 22 mg of metrizamide. (Auth.)

Contrast media for radiological examination in gastrointestinal tract leakage

International Nuclear Information System (INIS)

Ginai-Karamat, A.Z.

1987-01-01

The aim of this investigation has been to find a safe and suitable contrast medium (CM) for radiological evaluation of the gastrointestinal tract (GIT) in cases where leakage outside the GIT can be suspected. An experimental study was carried out to evaluate the reactions of various available CM in the bronchi and lungs, mediastinum, pleura and peritoneum of rats. The CM evaluated in the experimental study were, pure barium sulphate (without any additives), commercial barium sulphate (Micropaque, with additives), Dionosil, Hytrast, Gastrografin, Amipaque (in pleura Omnipaque) and Hexabrix. (Auth.)

Metrizamide in experimental selective renal angiography

International Nuclear Information System (INIS)

Pokorny, L.; Kelemen, J.

1981-01-01

Forty-seven dogs or seventy-four kidneys, respectively, were used in studies into the activity of metrizamide (Amipaque). The angiograms were of good quality; as compared with contrast media tested before, the incidence of abnormalities was somewhat lower, and the symptoms (spasm, inhomogeneous nephrogram) were less important. Histological examination showed that plenty of homogeneous pink proteinlike substance had accumulated in many tubules as well as in the lumen of the Bowman's capsules; fibroses were seen in several parts after 7 and 28 days, respectively. However, the evaluation of the renal function showed no considerable changes in the laboratory values. (orig.) [de

Effects of ioxaglic acid on cardiac functions during coronary arteriography in canines

Energy Technology Data Exchange (ETDEWEB)

Traegaardh, B. (Malmoe Allmaenna Sjukhus, Malmoe, Sweden); Lynch, P.R. (Temple Univ., Philadelphia, PA (USA). School of Medicine)

1983-01-01

The new monoacid dimer ioxaglic acid (P286), the non-ionic metrizamide (Amipaque) and diatrizoate (Renografin 76) were compared regarding their effects on left ventricular pressure, the first derivative of left ventricular pressure, aortic pressures and on ECG changes during left and right coronary angiography in dogs. Ioxaglate was found to affect most of these parameters less than diatrizoate probably due to its lower osmolality. Ioxaglate should be regarded suitable for coronary angiography. However, ioxaglate was found to have greater effects on the cardiac function than the equiosmolar metrizamide. This is probably due to the chemotoxicity of the anion or possibly to the sodium content of the ioxaglic acid solution.

The use of Metrizamid in experimental renal angiography

International Nuclear Information System (INIS)

Pokorny, L.; Kelemen, J.

1980-01-01

A possible application of the non-ionizing contrast material metrizamid (Amipaque Vascularsup(R), Amipaquesup(R)) for renal angiography was experimentally investigated in dogs. 1.5, 3, 10 or 25 ml contrast medium was injected into one kidney. The animals were killed immediately, 3 hours, 24 hours, 7 or 28 days after angiography, and the kidneys were histologically investigated. In several cases the angiograms showed small alterations (transitory vasospasm, inhomogeneous spots on the nephrogram). Histology revealed in the initial period a homogeneous, pinkish, protein-like substance in the Bowman capsule and in the lumen of the tubuli, whereas later infiltrations by round cells and local accumulation of connective tissues were found. (L.E.)

Hexabrix (ioxaglate), a new low osmolality contrast agent for lumbar epidural double-catheter venography

International Nuclear Information System (INIS)

Meijenhorst, G.C.H.; Bruin, J.N.T. de

1980-01-01

Hexabrix (ioxaglate), a new low osmolality contrast agent, has been compared with Telebrix (ioxitalamate) in a series of 50 lumbar epidural venograms. The intensity of the pain and heat sensation experienced by the patient was significantly lower following the injection of Hexabrix. For this reason Hexabrix may be considered the contrast medium of choice for epidural venography. In 15 additional cases Hexabrix was compared with Amipaque (metrizamide) in the same iodine concentration (320 mg/ml). In these patients hardly any difference in pain and heat sensation was observed after the injection of both contrast agents. Frequently only a slight feeling of warmth was noticed. A minimal sensation of pain was occasionally observed to the same degree with both contrast agents. (orig.)

Neuroradiological investigations and findings in spinal vascular disease

Energy Technology Data Exchange (ETDEWEB)

Vogelsang, H [Medizinische Hochschule Hannover (Germany, F.R.). Abt. fuer Neuroradiologie

1980-02-01

Neuroradiological examinations play a great role today in spinal blood flow disturbances due to spinal vascular disease. This goes for myelography with its new aqueous contrast medium Amipaque as well as for selective spinal arteriography, also with regard to therapeutical approaches (embolisation). Other causes of blood flow disturbances, however - with the exception of growing and displacing processes of the spinal column and spinal canal - cannot be detected by radiological methods or only indirectly; examinations with contrasting agents can only serve for diagnosis by exclusion. The article deals mainly with techniques and findings of examinations for spinal angioma which account for 7 to 11% of growing and displacing processes of the spine. Progress in diagnosis and therapeutical success has been accelerated by technical developments and new contrasting agents as well as by improved surgical techniques.

Comparison of side effects in myelography with iopamidol and metrizamide

International Nuclear Information System (INIS)

Lee, Yong; Kang, Heung Sik; Chang, Kee Hyun; Han, Seoul Heui; Kwon, Oh Sung; Myung, Ho Gin

1986-01-01

The study was conducted to compare the side effects in myelography of the two non-ionic water-soluble contrast medias, lopamidol (Niopam) and Metrizamide (Amipaque). A total of 111 patients were examined, 64 with lopamidol and 47 with Metrizamide. Side effects consisted of headache, nausea, vomiting, dizziness, urinary difficulty, muscular pain, seizure, neurobehavioral disturbance, neurological sign change, vital sign change and etc. The common side effects were headache, nausea, vomiting and dizziness in order of frequency. Most of the side effects were subsided within 24 hours following myelography. lopamidol myelography caused fewer and milder side effects than Metrizamide study. The side effects were more commonly observed in cervical, thoracic or total myelography than in lumbar myelography with either lopamidol or Metrizamide. There was no significant correlation between incidence of the side effects and premedication with phenobarbital or valium injection before myelography and CSF sampling during the procedure.

Comparison of side effects in myelography with iopamidol and metrizamide

Energy Technology Data Exchange (ETDEWEB)

Lee, Yong; Kang, Heung Sik; Chang, Kee Hyun; Han, Seoul Heui; Kwon, Oh Sung; Myung, Ho Gin [Seoul National University College of Medicine, Seoul (Korea, Republic of)

1986-12-15

The study was conducted to compare the side effects in myelography of the two non-ionic water-soluble contrast medias, lopamidol (Niopam) and Metrizamide (Amipaque). A total of 111 patients were examined, 64 with lopamidol and 47 with Metrizamide. Side effects consisted of headache, nausea, vomiting, dizziness, urinary difficulty, muscular pain, seizure, neurobehavioral disturbance, neurological sign change, vital sign change and etc. The common side effects were headache, nausea, vomiting and dizziness in order of frequency. Most of the side effects were subsided within 24 hours following myelography. lopamidol myelography caused fewer and milder side effects than Metrizamide study. The side effects were more commonly observed in cervical, thoracic or total myelography than in lumbar myelography with either lopamidol or Metrizamide. There was no significant correlation between incidence of the side effects and premedication with phenobarbital or valium injection before myelography and CSF sampling during the procedure.

Selective cervical myelography. Pt. 1

International Nuclear Information System (INIS)

Mironov, A.M.

1979-01-01

The classical ways of subarachnoid puncture - lumbal and suboccipital - require a considerable quantity of air in performing segmental cervical pneumomyelography. An examination technique is described, based on the recently suggested lateral subarachnoid puncture within the interarcus space at C 1 -C 2 level. Emphasis is laid on the possibilities of carrying out various neuro-roentgenological studies through contrast medium introduction in the fashion described, namely: pontocerebellar cistemography and cervical myelography with AMIPAQUE - a water soluble contrast medium. On the basis of literature data and personal experience it is stated that the risk in lateral subarachnoid puncture is by no means higher than in suboccipital puncture. The main advantages of selective cervical myelography effected by contrast medium injection through lateral subarachnoid puncture include the possibility to perform investigation with a minimum amount of air (4-8 cm 3 ) and to study patients with fixed, direct skull fraction after Crutchfield under maximum sparing conditions. (author)

Better and safer diagnostic possibilities with non-ionic contrast media

International Nuclear Information System (INIS)

Dalmstrom, K.; Svinn, K.

1991-01-01

The synthesis of contrast media for medical radiography is followed out since their introduction in late 50's. A discussion is presented on the genesis of undesirable side effects of ionic contrast media due to the sodium and meglumine cations, the hypertonicity of the media and the iodinated molecule itself. The advantages of the new non-ionic non-dissociating low osmolar contrast media is stressed and its low chemotoxicity is explained in the light of their chemical structure. The qualities of the specific representatives of new three generations of non-ionic contrast media are analysed and compared: 1) metrizamide (Amipaque, Nycomed) - a soluble monomer; 2) iopamidol (Iopamiro, Bracco), iohexol (Omnipaque, Nycomed), iopromid (Ultravist, Schering), iopentol (Imagopaque, Nycomed), ioversol (Optiray Mallincrodt) - monomers, more tolerable and with lower toxicity; 3) ioxaglat, iotrolan and iodixanol -monoacidic dimers with lower osmolarity. Results from clinical trial and monitoring programs in large patients' groups are presented. The severity and incidence of the observed side effects in different organs and systems including the risk's groups are given. Compared to the conventional ionic media, the occurence of undesired effects has been reduced to about 1/6 with the use of the new products. The review unabiguously show the advantages of the non-ionic contrast media. 6 tabs., 2 figs., 26 refs

An experimental study on tissue reaction of various contrast agents on mediastinum

International Nuclear Information System (INIS)

Chung, Jin Wook; Kim, Hyung Jin; Kim, Seung Hyup; Park, Jae Hyung; Chang, Kee Hyun

1989-01-01

Till now, there is no consensus about appropriate contrast agents for use in clinical investigation in suspected perforation of the esophagus. Gastrografin, most widely used water soluble contrast agent, is less sensitive in detection of fistulous tract and can induce pulmonary edema, leading to death occasionally, if aspirated. Barium sulphate has been contraindicated without actual evaluation of its effect on mediastinum by experimental and clinical study. The purpose of this experimental study is to evaluate the type of tissue reaction and its severity in mediastinum and, as a result, to propose appropriate contrast agents in various clinical situations of suspected esophageal leakage. Barium sulphate, Hytrat, Gastrografin, Telebrix, Hexabrix, Amipaque, Niopam, and Ultravist were injected into mediastinum of 20 rats in each. The tissue reaction of injection sites were examined microscopically and graded according severity of inflammatory reaction with serial follow up from 1 day to 8 weeks after injection. The results are as follows, 1. Barium sulphate and Hytrast produced highly significant (p<0.01) tissue reaction compared to saline group and early inflammatory reaction was more severe in Hytrast. 2. Water soluble agents produced no significant reaction in mediastinum compared to saline control group and proved to be safe in the situation of leakage into mediastinum. 3. Injected barium caused no death during 8 week follow up in spite of large injected amount and histologically produced localized indolent granuloma after 4 weeks which is expected not to cause any delayed complications. In consideration of above results, superior physical characteristics of barium sulphate and drawbacks of Gastrografin, we concluded as follows. 1. For postoperative assessment of esophageal anastomosis, Barium sulphate is the contrast agent of choice

Torsten Almén (1931-2016): the father of non-ionic iodine contrast media.

Science.gov (United States)

Nyman, Ulf; Ekberg, Olle; Aspelin, Peter

2016-09-01

The Swedish radiologist Torsten Almén is the first clinical radiologist ever to have made a fundamental contribution to intravascular contrast medium design, the development of non-ionic contrast media. He became emotionally triggered by the patients' severe pain each time he injected the ionic "high-osmolar" contrast media when performing peripheral arteriographies in the early 1960s. One day he got a flash of genius that combined the observation of pain, a pathophysiological theory and how to eliminate it with suitable contrast media chemistry. After self-studies in chemistry he developed the concept of iodine contrast media not dissociating into ions in solution to reduce their osmolality and even reach plasma isotonicity. He offered several pharmaceutical companies his concept of mono- and polymeric non-ionic agents but without response, since it was considered against the chemical laws of that time. Contrast media constructed as salts and dissociating into ions in solution was regarded an absolute necessity to achieve high enough water solubility and concentration for diagnostic purposes. Finally a small Norwegian company, Nyegaard & Co., took up his idea 1968 and together they developed the essentially painless "low-osmolar" monomeric non-ionic metrizamide (Amipaque) released in 1974 and iohexol (Omipaque) in 1982 followed by the "iso-osmolar" dimeric non-ionic iodixanol (Visipaque) released in 1993. This has implied a profound paradigm shift with regard to reduction of both hypertonic and chemotoxic side effects, which have been a prerequisite for the today's widespread use of contrast medium-enhanced CT and advanced endovascular interventional techniques even in fragile patients. © The Foundation Acta Radiologica 2016.

Cisternal myelography in dogs. Comparative study between Iopamidol and Metrizamide

International Nuclear Information System (INIS)

Thibaut, J.; Silva, C.G.; Vargas, L.; Born, R.; Deppe, R.

1992-01-01

With the aim of comparing two contrast medium utilized in myelography 12 adult dogs of both sexes and grouped into two groups (G1 and G2) of six dog each, were used. Both groups were previously anesthetized with sodium thiopental (20 mg/kg). Group 1 was injected via Cisterna magna into the subarachnoid space with metrizamide (Amipaque 6.75) in doses of 0,33 cc/kg. Group 2 was injected with iopamidol (Niopam 300) in doses of 0,26 cc/kg. For each animal, three series of four radiographs each were taken in ventro-dorsal and lateral projections at 5, 15 and 20 minutes after administering the contrast medium. During the course of the study, the dogs remained inclined in 20 deg in craneo-caudal direction in order to promote the caudal migration of the contrast medium. Radiographic plates of each dog obtained with the different treatments were simultaneously analyzed, comparing the characteristics of: advance speed of the contrast medium, the radiographic density and outlines and the possible appearance of adverse effects. Advance speed of the contrast medium into the subarachnoid space was greater with iopamidol, reaching an average of 20 vertebrae in the ventro-dorsal projection and an average of 21 vertebrae in the lateral projection. On the other hand metrizamide reached an average of 14 vertebrae in the ventro-dorsal projection and 16 vertebrae in the lateral projection. Radiographic density was lower with iopamidol, especially at 15 minutes allowing a greater contrast and therefore a better sight of the medullar structure. With regard to the outlines, these were neater with iopamidol, while with metizamide the outline was neat after 5 minutes, then became diffuse 15 and 20 minutes after being injected. No side effects were observed with the use of both contrast media